Front Street Capital Management, Inc. Sesen Bio, Inc. Transaction History

Front Street Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.95 - $2.46 $40,850 - $105,780	-43,000 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$0.69 - $1.47 $7,589 - $16,170	11,000 Added 34.38%	43,000 $44,000
Q4 2018 Feb 13, 2019	BUY	$0.96 - $2.04 $4,800 - $10,200	5,000 Added 18.52%	32,000 $45,000
Q3 2018 Nov 13, 2018	BUY	$1.54 - $2.38 $41,580 - $64,260	27,000 New	27,000 $58,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Front Street Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Front Street Capital Management, Inc. with notifications on news.